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RESEARCH ARTICLE
The immunomodulatory functions 
and molecular mechanism of a new bursal 
heptapeptide (BP7) in immune responses 
and immature B cells
Xiu Li Feng1,2* , Yang Zheng1,2, Man Man Zong1,2, Shan Shan Hao1,2, Guang Fang Zhou1,2, Rui Bing Cao1,2, 
Pu Yan Chen1,2 and Tao Qing Liu3*
Abstract 
The bursa of Fabricius (BF) is the acknowledged central humoural immune organ unique to birds and plays a vital 
role in B lymphocyte development. In addition, the unique molecular immune features of bursal-derived biological 
peptides involved in B cell development are rarely reported. In this paper, a novel bursal heptapeptide (BP7) with the 
sequence GGCDGAA was isolated from the BF and was shown to enhance the monoclonal antibody production of a 
hybridoma. A mouse immunization experiment showed that mice immunized with an AIV antigen and BP7 produced 
strong antibody responses and cell-mediated immune responses. Additionally, BP7 stimulated increased mRNA levels 
of sIgM in immature mouse WEHI-231 B cells. Gene microarray results confirmed that BP7 regulated 2465 differentially 
expressed genes in BP7-treated WEHI-231 cells and induced 13 signalling pathways and various immune-related func-
tional processes. Furthermore, we found that BP7 stimulated WEHI-231 cell autophagy and AMPK-ULK1 phosphoryla-
tion and regulated Bcl-2 protein expression. Finally, chicken immunization showed that BP7 enhanced the potential 
antibody and cytokine responses to the AIV antigen. These results suggested that BP7 might be an active biological 
factor that functions as a potential immunopotentiator, which provided some novel insights into the molecular 
mechanisms of the effects of bursal peptides on immune functions and B cell differentiation.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Undoubtedly, the most significant contribution that 
studies on the avian immune system have made to the 
development of mainstream immunology has been delin-
eating the two major arms of the adaptive immune sys-
tem, namely, humoural and cellular immunity [1–4]. 
Since surgical removal of the bursa from neonatal chicks 
impairs subsequent antibody responses to Salmonella 
typhimurium type O antigen [1], it is clear that the BF is 
the key location of B cell lymphopoiesis in birds [3, 4].
B cell development occurs in three distinct stages, 
namely, pre-bursal, bursal and post-bursal stages, and 
each of these stages plays a fundamentally different role 
in B cell development [5]. Furthermore, Liu et  al. [6] 
reported the transcriptional changes in mRNA expres-
sion in different developmental stages in the BF. A com-
plete understanding of the anatomy and function of the 
BF is lacking, and the mechanism underlying the involve-
ment of the BF in B cell development still needs to be 
profoundly elucidated.
B cell differentiation and antibody diversification are 
accompanied by the regulation of biologically active mol-
ecules and activation of immune induction [4]. Bursin 
tripeptide (Lys-His-Gly-NH2) was reported to be the first 
B cell-differentiating hormone derived from the BF [7, 
8], to selectively induce avian B cell differentiation, and 
to promote immunoglobulin (Ig) class switching from 
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IgM to IgG [9]. BP8, which has the sequence AGHTK-
KAP, can regulate various signalling pathways and reti-
nol-binding protein expression, which represents an 
important link between B cell development and retinol 
metabolism [10]. Bursal pentapeptide (BPP)-II regulates 
the expression of various genes involved in homologous 
recombination in DT40 avian pre-B lymphocyte cells and 
enhances antibody production in response to chicken 
immunization [11]. Furthermore, BP8 can promote 
colony-forming pre-B cell formation and regulate B cell 
development [12], and BP5, with the sequence CKDVY, 
regulates B cell development by promoting antioxidant 
defence [13]. BPP-II regulates more than one thousand 
differentially expressed genes that are involved in vari-
ous pathways and immune-related biological processes 
in hybridoma cells, which secrete monoclonal antibodies 
[14]. The avian immune system may provide important 
insights into fundamental immunological mechanisms, 
and the chicken may be the best-studied non-mammalian 
species [15].
To investigate the function and molecular basis of bur-
sal-derived peptides in the immune response and imma-
ture B cells, in this study, we isolated a new peptide, BP7, 
from the BF with RP-HPLC and MS/MS analysis and 
showed the inducing roles of BP7 in immune responses 
to vaccination. Furthermore, we applied a gene micro-
array to screen the gene expression profiles of imma-
ture mouse B cells after BP7 treatment and analysed the 
enriched pathways and function categorization of the dif-
ferentially expressed genes in the immature B cells. The 
results provided some vital information on the mecha-
nisms involving the bursal peptide in immune induction 
and immature B cell development.
Materials and methods
Animal
BALB/c female mice (approximately 19 g) were obtained 
from the experimental animal centre of Yangzhou Uni-
versity (Yangzhou, China). Seventy-five-day-old female 
chickens were purchased from Qinglongshan Farm (Nan-
jing, China). Experiments were conducted following the 
guidelines of the Animal Ethics Committee at Nanjing 
Agricultural University, China. The euthanasia and sam-
pling procedures complied with the “Guidelines on Ethi-
cal Treatment of Experimental Animals” (2006) No. 398 
published by the Ministry of Science and Technology, 
China and “the Regulation regarding the Management 
and Treatment of Experimental Animals” (2008) No. 45 
published by the Jiangsu Provincial People’s Government.
RP‑HPLC and MS analysis
As described previously [14] with some modifications, an 
extract of the BF was sequentially separated and purified 
to isolate soluble peptides from bursal samples. Briefly, 
50 g bursa tissues from a 1-month-old AA broiler chick 
without fascia or adipose tissue were washed once with 
0.85% physiological saline (pre-cooled to 4–10  °C) and 
placed in a tissue homogenizer, and then the pre-cooled 
0.85% saline buffer was added to the tissues. After the 
homogenization process and ultrasonic treatment were 
completed, a pyrolysis solution was heated to 80  °C for 
5 min, quickly placed on ice and cooled to 10 °C, and then 
centrifuged at 4000  g/min for 30  min. The supernatant 
was collected, frozen and thawed twice, and centrifuged 
at 12 000 g/min for 30 min at 4 °C. The supernatant was 
ultrafiltered with a molecular weight cutoff of 1000  Da 
and purified on a SinoChrom ODS-BP RP-HPLC affinity 
column (C-18 Aqua column, 150 × 4.6  mm) following a 
linear gradient of acetonitrile (2–100%) in Agilent 1100 
series high-performance liquid chromatograph at 25  °C. 
The acetonitrile-soluble fraction based on the elution 
time was collected and analysed using a mass spectrom-
eter (SHIMADZU LC-AB SCIEX Triple TOF 4600) and 
further analysed with MS/MS to obtain the exact amino 
acid sequence analysed by Nanjing GenScript Bioscience 
Co., Ltd. (Nanjing, China); the detailed information is 
listed in Additional file 1A.
Peptide synthesis
A bursal-derived peptide was synthesized by Nanjing 
GenScript Bioscience Co., Ltd. (Nanjing, China) with 
a purity over 95% and was analysed by HPLC and mass 
spectrometry.
Hybridoma cell treatment
Hybridoma cells  (105 cells/mL) were seeded in a 96-well 
plate and treated with or without the synthesized BP7 
peptide (1, 0.1, or 0.01  μg/mL), and the antibody levels 
in the cell supernatant at 48 h were determined by ELISA 
[14, 16]. Cell viabilities were determined with an MTT 
reagent (Sigma) according to the manufacturer’s instruc-
tions as follows: the relative survival or antibody stimu-
lation index (%) = ((absorbance of BP7 treatment-blank)/
(absorbance of control-blank)) × 100%. Additionally, 
hybridoma cells were treated with BSA at 0.1  μg/mL as 
a control.
Mouse immunization and detection protocols
To investigate whether BP7 performs immunoregula-
tory functions as an immunopotentiator, we intraperi-
toneally immunized mice with 0.2 mL AIV antigen with 
or without the synthesized BP7 peptide on days 0 and 14 
according to a previously reported immune programme 
[14, 17]. On the  28th day after immunization, we col-
lected serum samples from all mice and detected anti-
body titres and antibody subtypes by ELISA [15]. On the 
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 7th day after the second immunization, serum samples 
were collected from all immunized mice to detect IL-4 
and IFN-γ cytokine production by ELISA kits (RD, USA), 
and splenic lymphocytes were isolated to classify T cell 
immunophenotyping by using fluorophore-labelled anti-
CD3, anti-CD4, and anti-CD8 antibodies. Furthermore, 
the splenic lymphocytes collected from all experimental 
groups were treated with an inactivated AIV H9N2 anti-
gen to assess lymphocyte viabilities.
WEHI‑231 cell treatment
WEHI-231 cells were treated with the synthesized BP7 
peptide at concentrations ranging from 0.01 to 1  μg/
mL for 4 h, cell viability was tested with MTT methods, 
and the sIgM levels of WEHI-231 cells were detected 
with qPCR. Additionally, WEHI-231 cells were treated 
with 0.1  μg/mL BSA as a control. The primers for 
mouse sIgM were primer-F-gtggaatctggcttcaccac and 
primer-R-cattcaggttcagccagtcg.
Microarray assay and data analysis
According to previous methods [14, 18] with some modi-
fications, total RNA was extracted from WEHI-231 
cells treated with 0.1  μg/mL BP7 for 4  h by using TRI-
zol reagent (Invitrogen) and processed for hybridization 
according to the manufacturer’s instructions. Three inde-
pendent experiments were performed. Gene expression 
profiles were detected with an Agilent mouse (V2) gene 
expression microarray (8 × 60  K, Agilent) and scanned 
with the Agilent G2565CA Microarray Scanner. The 
resulting data were analysed with AgilentGeneSpring 
GX software. A fold change of 2.0 with a 95% signifi-
cance level was selected as the threshold for comparisons 
between paired cell lines. For the exploration of pathways 
and processes involved in the development of immature 
B cells in WEHI-231 cells, we also conducted a functional 
analysis with a threshold of a p value less than 0.05.
Quantitative real‑time reverse transcription PCR
Total RNA was prepared from WEHI-231 cells treated 
with 0.1  μg/mL BP7 using TRIzol reagent. Six sig-
nificantly differentially expressed genes in WEHI-
231 cells were checked using the One Step  SYBR® 
PrimeScript™ RT-PCR Kit (Takara, Shiga, Japan), includ-
ing Sos1, Atg14, Atg12, Ube2b, Pias3, and Ifnb1. qRT-
PCR was performed using an ABI 7300 Real-Time PCR 
system (Applied Biosystems) according to the manu-
facturer’s specifications. The primers for these selected 
genes in WEHI-231 cells, which were analysed with the 
 2−ΔΔCt method using Actin as an internal control, are 
shown in Additional file 2.
Transmission electron microscopy
According to reported methods [19], WEHI-231 cells 
were treated with 10 μg/mL synthesized BP7 for 24 h and 
then collected by centrifugation at 1000  rpm for 10  min. 
BSA (10 μg/mL) was used as a control. After washing, the 
WEHI-231 cells were fixed with 2.5% glutaraldehyde and 
1% osmium tetroxide. After dehydration with a 50–100% 
(with a 10% gradient) series of ethanol and pure acetone, 
the WEHI-231 cells were embedded, cut and stained with 
uranyl acetate and lead citrate Zi to image the autophago-
somes in the WEHI-231 cells with a H7650 transmission 
electron microscope (HITACHI, Japan).
Western blot analysis
WEHI-231 cells were treated with the synthesized BP7 
peptide at concentrations ranging from 0.001 to 50  μg/
mL for 24 h, and then total protein was isolated from the 
WEHI-231 cells using a cell culture lysis reagent (Promega) 
following the manufacturer’s instructions. Western blotting 
was performed as described previously [19] using mouse 
anti-mouse monoclonal antibodies against LC3 (E1A4007-
1, EnoGene, China), AMPK (5832T, CST), p-AMPK 
(2535T, CST), ULK1 (8054T, CST), p-ULK1 (5869T, CST), 
and Bcl-2 (E1A6139, EnoGene, China). The expression of 
the internal reference protein GAPDH was detected with 
a rabbit anti-mouse GAPDH antibody (E12-052-1, Eno-
Gene). Additionally, WEHI-231 cells were treated with 
10 μg/mL BSA as a negative control or rapamycin as a posi-
tive control.
Avian immunization
Seventy-five-day-old chickens were subcutaneously 
injected twice with 0.2  mL AIV vaccine with or without 
0.05 mg/mL synthesized BP7 on days 0 and 14. On the  14th 
and  28th day after immunization, we collected serum sam-
ples from all immunized chickens to detect HI antibody 
titres. Additionally, on the  7th day after the second immu-
nization, serum samples were collected to detect IL-4 and 
IFN-γ cytokine production by ELISA kits (RD), and splenic 
lymphocytes were isolated to detect lymphocyte viability.
Statistical analysis
The results are illustrated in bar graphs as the 
mean ± standard deviation (SD) of three independent 
experiments. Statistical significance was analysed by t tests 
or one-way ANOVA with the threshold for a significant 
difference set at 0.05.
Results
Isolation and identification of the bursal‑derived peptide 
BP7
In this paper, an ultrasonic sample of a bursal extract 
was isolated and analysed by RP-HPLC coupled to 
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MALDI-TOF-MS and MS/MS analysis, and a new bur-
sal peptide was separated in a peak at 17.09  min (Fig-
ure 1A). The amino acid sequence was analysed with MS/
MS (Additional file  1B), a seven-amino acid sequence, 
GGCDGAA (namely, BP7), was obtained (Additional 
file 1C), and the chemical structure is shown in Figure 1B.
By aligning the sequence of BP7 in the non-redundant 
and Expressed Sequence Tag databases of NCBI, we 
found that BP7 was similar to proteins from Gallus gal-
lus and mice, suggesting that BP7 was conserved in both 
these species and was probably a proteolytic degrada-
tion fragment of an intact protein; there were two pro-
teins of interest in G. gallus (Additional file 3) including 
interferon-induced helicase C domain-containing protein 
1 (IFIH1; NP_001180567.1) and immunoglobulin heavy 
chain variable region (IGHV; CAO79246.1). Additionally, 
we blasted the amino acid sequence GGCDGAA in Lac-
tobacillus and Escherichia coli and did not find proteins 
in these bacteria with exactly the same sequence as that 
of BP7.
To confirm the inducing role of BP7 in antibody pro-
duction, hybridoma cells secreting an antibody specific 
for JEV were used as an in vitro model [16]. The results 
showed that compared to control treatment, BP7 treat-
ment enhanced the monoclonal antibody production lev-
els of the hybridoma cells by ELISA (Figure 1C), in which 
the antibody levels were increased by 45.91%, 52.1% and 
27.55% at 0.01, 0.1 and 1 μg/mL BP7 treatment, respec-
tively. However, hybridoma cell proliferation did not 
significantly differ with 0.01 to 1  μg/mL BP7 treatment 
compared with control treatment (Figure 1C).
BP7 induced an immunomodulatory response 
to immunization in mice
To evaluate the immune-inducing roles of BP7 in immu-
nization, the subtypes of AIV-specific antibodies present 
at 4 weeks after immunization were analysed by ELISA. 
For IgG1, all serum samples were diluted 1:104. It was 
observed that mice immunized with an AIV antigen 
and three concentrations of BP7 produced significantly 
increased IgG1 antibody levels compared with mice 
immunized with a control antigen, and the IgG1 levels 
of the mice immunized with the AIV antigen and 50 μg/
mL BP7 were the highest among those of the mice in all 
experimental groups (Figure 2A). Additionally, the serum 
samples from the mice in all groups were diluted at 1:103 
to detect IgG2a levels. We found that the mice immu-
nized with the AIV vaccine and BP7 produced higher 
levels of IgG2a antibodies than the mice immunized with 
the control antigen, and the elevated levels exhibited a 
dose-dependent pattern (Figure 2A).
To assess the capability of BP7 to elicit Th1- and Th2-
type immune responses, on the  7th day after the second 
immunization, we detected the levels of the cytokines 
IFN-γ and IL-4 in serum samples from all groups using a 
mouse ELISA kit. The data suggested that the production 
of IL-4 in the mice immunized with the AIV antigen and 
10 μg/mL BP7 was significantly higher than that in those 
immunized with a control AIV antigen, while the levels 
of IFN-γ were not significantly different among all immu-
nization groups, although decreased IFN-γ production 
was observed in the mice treated with the AIV antigen 
and 250 μg/mL BP7 (Figure 2B).
Figure 1 Isolation and identification of BP7. A The isolation and purification of BP7. B MS/MS analysis of the amino acid sequence of BP7. C 
Antibody production of hybridoma cells enhanced by BP7. Data represent the mean ± standard deviation (s.d.). Significant differences between 
groups were determined using Student’s t-test, and p < 0.05 is indicated by an asterisk (*).
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Additionally, 1 week after the second immunization, 
CD4+ T cell percentages in the mice immunized with 
10 or 50 μg/mL BP7 were significantly higher than those 
in the control mice, and CD8+ T cell percentages in the 
mice immunized with 50  μg/mL BP7 were significantly 
higher than those in the control mice (Figure 2C). After 
antigen stimulation, the cell viabilities in the mice immu-
nized with the AIV antigen and 10 or 50  μg/mL BP7 
were significantly higher than those in the control mice 
(Figure 2D).
Inducing effects of BP7 on immature B cells
To detect the roles of BP7 in immature B cells, WEHI-
231 cells were used as a mouse model of immature B cells 
and treated with BP7 at concentrations ranging from 
0.01 to 1 μg/mL. As shown in Figure 3A, the sIgM level 
in the WEHI-231 cells treated with 0.1  μg/mL BP7 was 
significantly higher than that in the PBS-treated control 
cells. Additionally, the sIgM level in the WEHI-231 cells 
treated with 0.1 μg/mL BP7 was higher than that in the 
BSA-treated control cells (Figure 3B).
Gene expression profile analysis of WEHI‑231 cells 
that received BP7 treatment and validation
To investigate the gene expression patterns induced by 
the bursal-derived peptide in immature B cells as well as 
the associated functional classifications, mouse WEHI-
231 cells were treated with 0.1  μg/mL BP7 for 4  h, and 
the gene expression profiles of the BP7-treated WEHI-
231 cells were analysed by a mouse cDNA microarray. 
Heat maps illustrate the overall expression profiles of 
the WEHI-231 cells treated with BP7 (Figure 3C). With 
the use of specified thresholds, 1124 upregulated genes 
and 1341 downregulated genes were observed in the 
BP7-treated WEHI-231 cells compared with the control 
cells (Figure  3D, Additional file  4); the fold changes in 
the expression of most genes in the WEHI-231 cells and 
DT40 cells given BP7 treatment were between 1 and − 1 
log (2) ratios (Figure 3D).
To validate the differentially expressed genes by gene 
microarrays, the expression levels of six genes were 
determined using qRT-PCR. The results showed that the 
expression levels of Sos1, Atg14 and Atg12 were higher 
Figure 2 BP7 induced various immune responses in mice immunized with an AIV antigen. BALB/c mice were immunized with BP7 and 
an AIV  H9N2 antigen following a prime-boost vaccination strategy. A Antibody subtypes, B cytokine production, C T cell populations, and D 
lymphocyte viability. Data represent the mean ± standard deviation (s.d.). Significant differences between groups were determined using Student’s 
t-test, where p < 0.05 and p < 0.01 are indicated by asterisks (* and **, respectively).
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and those of Ube2b, Pias3 and Ifnb1 were lower in the 
BP7-treated WEHI-231 cells than in the control cells 
(Figure 3E). These results were consistent with the micro-
array analysis of BP7-treated WEHI-231 cells.
BP7 induced enriched signals and pathways in WEHI‑231 
cells
To attain an overview of biological pathway regula-
tion in immature B cells, we analysed signalling and 
Figure 3 Roles of BP7 and BP7‑induced gene expression profiles in WEHI‑231 cells. WEHI-231 cells were treated with BP7 for 4 h. sIgM 
levels were detected by qPCR (A, B). C A heat map shows the gene expression profiles of BP7-treated WEHI-231 cells. D The histogram presents 
differentially expressed genes. E The differentially expressed genes in WEHI-231 cells were validated. Data represent the mean ± standard deviation 
(s.d.). Significant differences between groups were determined using Student’s t-test, where p < 0.05 is indicated by an asterisk (*).
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metabolic pathways in the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database. It was found 
that the differentially expressed genes induced in 
WEHI-231 cells by BP7 were involved in 13 pathways, 
of which five were related to biosynthesis and metabo-
lism, five were related to signalling pathways, and three 
were related to other pathways (Additional file 5). Fur-
thermore, we analysed the enriched-pathway network 
of WEHI-231 cells given BP7 treatment, as shown in 
Figure 4A. Ubiquitin-mediated proteolysis, which was 
related to various pathways in the BP7-treated WEHI-
231 cells, was the most enriched pathway among all 
the involved pathways in the WEHI-231 cells treated 
with BP7.
BP7 induced various GO functional processes in WEHI‑231 
cells
To further investigate the molecular basis involving 
BP7 in the biological functions of immature B cells, 
the genes with differential expression in WEHI-231 
cells after BP7 treatment were analysed based on GO 
terms, and the significantly enriched terms with p 
values within TOP30 are summarized in Figure  4B. 
There were 22 biological processes, four cellular com-
ponents, and four molecular functions among the GO 
terms with p values within TOP30 in the BP7-treated 
WEHI-231 cells (Figure 4B).
Differential expression of immune‑related functional 
processes in BP7‑treated WEHI‑231 cells
To characterize the molecular signature of the host 
immune system, we analysed the expression of genes 
involved in immune-related functional processes, which 
included T cell proliferation and activation, antigen 
processing and presentation, T helper 2 cell differentia-
tion, the MHC I and II biosynthetic process and regu-
lation, interleukin and autophagy in the mouse B cell 
line WEHI-231 after BP7 treatment. The differentially 
expressed genes are shown in Additional file 6.
BP7 induced autophagy and AMPK‑ULK1 phosphorylation 
in immature B cells
To detect the role of BP7 in autophagy in WEHI-231 
cells, autophagosome formation was observed using a 
transmission electron microscope. The results showed 
that compared with control cells, WEHI-231 cells treated 
with 10  μg/mL BP7 exhibited significant autophago-
somes (Figure 5A). Additionally, the protein levels of LC3 
at experimental concentrations of 10 and 1 μg/mL were 
increased in BP7-treated WEHI-231 cells (Figure  5B). 
These results indicated that BP7 could induce autophagy 
in immature B cells.
To investigate the potential signalling involving BP7 
in autophagy in immature B cells, in this paper, we 
detected AMPK-ULK1 phosphorylation in WEHI-231 
cells treated with BP7. It was observed that 10  μg/mL 
BP7 stimulated the expression of p-AMPK (Figure 5C). 
Figure 4 Pathway interaction network and significant GO terms with a p value within TOP30 in WEHI‑231 cells treated with BP7. A The 
pathway network analysis of 13 significantly enriched pathways (shown in Additional file 5) and B summarized significant GO terms with a p value 
within TOP30.
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Additionally, we observed that 10  μg/mL BP7 induced 
increased expression of ULK1, and BP7 at concen-
trations ranging from 0.01 to 10  μg/mL stimulated 
increased expression of p-ULK1 in treated WEHI-231 
cells compared with control cells (Figure  5C). These 
results suggested that AMPK-ULK1 phosphorylation 
might be the activating signal for autophagy in imma-
ture B cells treated with BP7.
Furthermore, we found that the expression of Bcl-2 
was significantly increased with BP7 treatment at con-
centrations of 1 and 10  μg/mL compared to control 
treatment (Figure  5D), and 1  μg/mL BP7 induced the 
highest expression of Bcl-2 among all experimental 
treatments.
BP7 induced a strong immune response to immunization 
in chickens
To investigate the roles of BP7 in avian immunization, 
75-day-old chickens were immunized twice with an AIV 
antigen and 50  μg/mL BP7. The results showed that at 
2 and 4 weeks after immunization, HI antibody titres in 
the chickens immunized with the AIV antigen and BP7 
were higher than those in the antigen control-immunized 
chickens (Figure  6A). Additionally, on the  7th day after 
Figure 5 BP7 induced autophagy and enhanced AMPK‑ULK1 phosphorylation and BCL‑2 expression in WEHI‑231 cells. A Transmission 
electron microscopy of autophagosome formation in WEHI-231 cells treated with 10 μg/mL BP7. The arrow indicates autophagosomes in WEHI-231 
cells. B LC3 protein expression. C AMPK-ULK1 phosphorylation. D Expression levels of BCL-2. In B and C, WEHI-231 cells treated with 10 μg/mL BSA 
were used as the irrelevant control (Control), and those treated with rapamycin were used as the positive control. In D, WEHI-231 cells treated with 
10 μg/mL BSA were used as the irrelevant control (Control), and those treated with Dox were used as the positive control. Representative Western 
blots are shown.
Page 9 of 12Feng et al. Vet Res           (2019) 50:64 
the second immunization, the levels of the cytokines IL-4 
and gamma IFN in the chickens immunized with the AIV 
antigen and BP7 were higher than those in the antigen 
control-immunized chickens (Figure  6B). Additionally, 
we observed that the splenic lymphocyte viabilities of 
the chickens immunized with the AIV antigen and BP7 
were higher than those of the antigen control-immunized 
chickens (Figure  6C). These results suggested that BP7 
might induce strong immune responses in avian immu-
nization models.
Discussion
The BF is the central organ for B cell development in 
birds and is the primary site of B cell lymphopoiesis 
[2–4]. However, few studies have reported the unique 
molecular basis and mechanism of bursal-derived biolog-
ical peptides in immune responses and immature B cell 
development.
In this paper, one new heptapeptide (BP7) was iso-
lated from the avian bursa and found to be homologous 
to various proteins in G. gallus and Mus musculus, sug-
gesting that BP7 is conserved among various species; BP7 
was also found to be homologous to interferon-induced 
helicase C domain 1 protein (IFIH1) and immunoglob-
ulin heavy chain variable region (IGHV) in G. gallus. 
IFIH1 can function as a pattern recognition receptor that 
activates innate immune responses upon binding with 
damage-associated molecular patterns [20, 21]. Another 
homologous protein, immunoglobulin heavy chain vari-
able region (IGHV), was reported to be significantly 
correlated with Tfh17 cells [22] and relevant somatic 
mutations, such as antigen-driven affinity maturation 
[23]. Furthermore, BP7 stimulated increased monoclonal 
antibody production in hybridoma cells. Antibody pro-
duction is one of the vital behaviours for B cell differen-
tiation and maturation. These results indicated that BP7 
could be an inducing factor in antibody production and B 
cell development.
Additionally, we performed a blast search for proteins 
homologous to BP7 with the amino acid sequence of 
GGCDGAA in Lactobacillus and E. coli, which are the 
bacteria commonly present in the chicken intestine, and 
did not find proteins in these bacteria with a sequence 
identical to that of BP7, which suggested that BP7 is 
derived from avian BF tissue. In future studies, we will 
further analyse the distribution and function of BP7 in 
the chicken BF.
Mice are a commonly used animal research model for 
investigating the regulatory and adjuvant functions of 
biologically active peptides in immune responses [14, 
24, 25]. To evaluate the inducing effects on immune 
responses, in this paper, we primarily selected BALB/c 
female mice as the experimental animal model. The 
results proved that BP7 promoted IgG1 and IgG2a anti-
body production, in which IgG1 was the major antibody 
subtype in the mice immunized with an AIV antigen and 
BP7. Additionally, BP7 stimulated increases in IL-4 levels 
and T cell subpopulation numbers in models in immu-
nization experiments. The IgG1 and IgG2α isotypes are 
both important IgG subclasses during vaccination [26, 
27]. It was reported that the IgG2a subclass is a charac-
teristic of the Th1-type immune response, while IgG1 is 
a representative factor of the Th2-type immune response 
[28, 29]. IL-4 plays an essential role during Th pheno-
typic development in Th2 cells, which might be impor-
tant for humoural immunity and B cell development [30], 
and IFNγ can boost CD8+ T cell- and non-specific cell-
mediated protective immune responses [29, 31]. These 
results suggested that BP7 primarily elicited Th1 immune 
responses and played a role in the Th2-type immune 
response in the AIV antigen-immunization model.
WEHI-231 cells are a mouse peripheral B cell model 
that is a common immature B cell model used to study 
Figure 6 Inducing roles of BP7 in a chicken immunization model. Chickens were immunized twice with BP7 and an AIV  H9N2 antigen. A 
HI antibody levels. B IL-4 and IFN-γ cytokine production. C Lymphocyte viability. Data represent the mean ± standard deviation (s.d.). Significant 
differences between groups were determined using Student’s t-test, where p < 0.05 is indicated by an asterisk (*).
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the function and mechanism of B cells [32]. To investi-
gate the roles of BP7 in immature B cells, we detected 
the roles of BP7 in WEHI-231 cells. The results proved 
that BP7 significantly induced increased sIgM levels in 
WEHI-231 cells. We found 2465 differentially expressed 
genes in BP7-treated WEHI-231 cells compared with 
control cells by gene microarray analysis. Furthermore, 
the differentially expressed genes were involved in 13 sig-
nificantly enriched pathways in the BP7-treated WEHI-
231 cells, of which ubiquitin-mediated proteolysis was 
the vital pathway. Ubiquitin-mediated processes have 
been reported to participate in MHCII complexes, which 
facilitate the B cell response and selection in germinal 
centres [33] and B cell receptor signalling [34]. These 
results proved the substantial mechanism underlying the 
effects of BP7 on the gene expression profile and signal-
ling pathways in WEHI-231 cells, suggesting that BP7 
might play a vital role in immature B cell development.
To investigate the molecular basis of the function of 
BP7 in immature B cells, we further analysed enriched 
GO terms with p values within TOP30 in WEHI-231 
cells after BP7 treatment. It was observed that among 
the GO terms with p values within TOP30, 73.33% of the 
GO terms belonged to biological processes and 13.33% 
belonged to molecular functions in the BP7-treated 
WEHI-231 cells. In this paper, we further investigated 
the molecular mechanism underlying the role of BP7 
in immune induction in immature mouse B cells. The 
immune-related GO terms and differentially expressed 
genes involved in BP7-treated WEHI-231 cells consisted 
of negative regulation of T cell and lymphocyte prolifera-
tion, T helper 2 cell differentiation, antigen processing 
and presentation, MHC class II and MHC class I biosyn-
thetic processes, B cell activation and B cell-mediated 
immunity, and cytokine activity and secretion. The acti-
vation and proliferation of lymphocytes, including T and 
B cells, play vital roles in adaptive immune responses 
during vaccination [35, 36]. MHC class II and MHC class 
I are both principal components in antigen processing 
and presentation pathways [37]. These results suggested 
that BP7 might participate in various immune-related 
biological processes, resulting in multifunctional induc-
ible functions in both humoural and cellular immune 
responses.
Autophagy is involved in various immune-related bio-
logical processes, including the development of B and T 
cells, antigen presentation by B cells, and the survival of 
memory lymphocytes and antibody-producing plasma 
cells [38–40]. In this study, BP7 regulated various dif-
ferentially expressed genes involved in the autophagy 
pathway and autophagy-related biological processes, 
increased intracellular autophagosome formation and 
stimulated the expression of the LC3 protein in WEHI-
231 cells. Additionally, we found that BP7 promoted 
AMPK and ULK1 phosphorylation and induced BCL-2 
expression in WEHI-231 cells. An interaction between 
AMPK and the PS domain of ULK1 is required for 
ULK1-mediated autophagy [41]. Bcl-2 family mem-
bers are dual regulators of apoptosis and autophagy 
[42]. These results suggested that BP7 could induce 
autophagy in immature B cells. However, the function 
and mechanism of autophagy induced by BP7 stimula-
tion in immature B cell development and differentiation 
needs to be further explored in future work.
The regulatory function of active peptides in animal 
models is an important reference for clinical appli-
cations. In this study, we observed that BP7 induced 
strong antibody and cytokine responses in chicken 
immunization experiments. These results proved that 
BP7 could act as an immune-enhancing agent for an 
AIV vaccine, providing an important reference for clin-
ical disease prevention and vaccine improvement.
In brief, the BF plays vital roles in B cell differentia-
tion and antibody production, in which bursal-derived 
peptides may be involved in various functional pro-
cesses and signalling activation during B cell develop-
ment. In this study, a new regulatory heptapeptide, 
BP7, was isolated from the BF and induced strong anti-
body responses and cell-mediated immune responses 
specific to an AIV antigen in mouse immunization 
experiments and significantly increased sIgM levels in 
immature mouse B cells. Furthermore, BP7 regulated 
the expression of various genes involved in signalling 
pathways and immune-related biological processes and 
regulated autophagy through AMPK-ULK1 phospho-
rylation in immature B cells. Finally, BP7 promoted 
strong immune responses to the AIV antigen in chicken 
vaccination. These results provide novel insights into 
the molecular mechanism involving this bursal peptide 
in immune functions and B cell development.
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